{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T06:17:57Z","timestamp":1768285077944,"version":"3.49.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.ejphar.2014.04.024","type":"journal-article","created":{"date-parts":[[2014,4,24]],"date-time":"2014-04-24T14:37:11Z","timestamp":1398350231000},"page":"184-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Protective effect of 7-O-succinyl macrolactin A against intestinal inflammation is mediated through PI3-kinase\/Akt\/mTOR and NF-\u03baB signaling pathways"],"prefix":"10.1016","volume":"735","author":[{"given":"Sumin","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushil Chandra","family":"Regmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Kyoung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Hoon","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sae Kwang","family":"Ku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Ae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2014.04.024_bib1","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev.immunol.14.1.649","article-title":"The NF-kappa B and I kappa B proteins: new discoveries and insights","volume":"14","author":"Baldwin","year":"1996","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2014.04.024_bib2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/bjc.1993.298","article-title":"Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies","volume":"68","author":"Banks","year":"1993","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejphar.2014.04.024_bib3","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1056\/NEJM199704103361506","article-title":"Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases","volume":"336","author":"Barnes","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2014.04.024_bib4","doi-asserted-by":"crossref","first-page":"G1237","DOI":"10.1152\/ajpgi.90537.2008","article-title":"A novel mTOR inhibitor is efficacious in a murine model of colitis","volume":"295","author":"Bhonde","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.ejphar.2014.04.024_bib5","first-page":"135","article-title":"Transcriptional regulation of endothelial cell adhesion molecules: a dominant role for NF-kappa B","volume":"47","author":"Chen","year":"1995","journal-title":"Agents Actions Suppl."},{"key":"10.1016\/j.ejphar.2014.04.024_bib6","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1053\/gast.2001.23983","article-title":"Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis","volume":"120","author":"D\u05f3Haens","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2014.04.024_bib7","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1101\/gad.1662308","article-title":"Akt-dependent regulation of NF-{kappa}B is controlled by mTOR and Raptor in association with IKK","volume":"22","author":"Dan","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejphar.2014.04.024_bib8","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1136\/gut.34.11.1593","article-title":"Expression of intercellular adhesion molecule 1 (ICAM-1, CD54) in colonic epithelial cells","volume":"34","author":"Dippold","year":"1993","journal-title":"Gut"},{"key":"10.1016\/j.ejphar.2014.04.024_bib9","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1365-2249.1995.tb03836.x","article-title":"Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)","volume":"102","author":"Duchmann","year":"1995","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ejphar.2014.04.024_bib10","doi-asserted-by":"crossref","first-page":"26448","DOI":"10.1074\/jbc.274.37.26448","article-title":"Inhibition of interleukin-1-stimulated NF-kappaB RelA\/p65 phosphorylation by mesalamine is accompanied by decreased transcriptional activity","volume":"274","author":"Egan","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2014.04.024_bib11","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s000110050358","article-title":"Activation of nuclear factor kappa B in Crohn\u05f3s disease","volume":"47","author":"Ellis","year":"1998","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.ejphar.2014.04.024_bib12","series-title":"Inflammatory Bowel Disease: From Bench to Bedside","first-page":"67","article-title":"Experimental mouse models of inflammatory bowel disease: new insights into pathogenic mechanisms","author":"Elson","year":"2005"},{"key":"10.1016\/j.ejphar.2014.04.024_bib13","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00384-005-0793-7","article-title":"Rapamycin decreases leukocyte migration in vivo and effectively reduces experimentally induced chronic colitis","volume":"21","author":"Farkas","year":"2006","journal-title":"Int. J. Colorectal Dis."},{"issue":"Suppl.","key":"10.1016\/j.ejphar.2014.04.024_bib14","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S0092-8674(02)00703-1","article-title":"Missing pieces in the NF-kappaB puzzle","volume":"109","author":"Ghosh","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2014.04.024_bib15","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/sj.cdd.4401285","article-title":"M-CSF, TNF\u03b1 and RANK ligand promote osteoclast survival by signaling through mTOR\/S6 kinase","volume":"10","author":"Glantschnig","year":"2003","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejphar.2014.04.024_bib16","doi-asserted-by":"crossref","first-page":"7519","DOI":"10.1021\/ja00201a036","article-title":"The macrolactins, a novel class of antiviral and cytotoxic macrolides from a deep-sea marine bacterium","volume":"111","author":"Gustafson","year":"1989","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejphar.2014.04.024_bib17","doi-asserted-by":"crossref","first-page":"G1357","DOI":"10.1152\/ajpgi.2001.281.6.G1357","article-title":"Akt protects mouse hepatocytes from TNF-\u03b1-and Fas-mediated apoptosis through NK-\u03baB activation","volume":"281","author":"Hatano","year":"2001","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.ejphar.2014.04.024_bib18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.vascn.2003.12.002","article-title":"Animal models of inflammatory bowel disease","volume":"50","author":"Jurjus","year":"2004","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejphar.2014.04.024_bib19","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0016-5085(99)70182-4","article-title":"Mesalamine blocks tumor necrosis factor growth inhibition and nuclear factor kappaB activation in mouse colonocytes","volume":"116","author":"Kaiser","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2014.04.024_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/science.270.5233.50","article-title":"PIK-related kinases: DNA repair, recombination, and cell cycle checkpoints","author":"Keith","year":"1995","journal-title":"Science-New York then Washington"},{"key":"10.1016\/j.ejphar.2014.04.024_bib21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature10209","article-title":"Genetics and pathogenesis of inflammatory bowel disease","volume":"474","author":"Khor","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2014.04.024_bib22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s12272-011-0117-0","article-title":"Antibacterial activities of macrolactin a and 7-O-succinyl macrolactin a from Bacillus polyfermenticus KJS-2 against vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus","volume":"34","author":"Kim","year":"2011","journal-title":"Arch. Pharmacal Res."},{"key":"10.1016\/j.ejphar.2014.04.024_bib23","first-page":"7","article-title":"Neuronal cell protection activity of macrolactin A produced by Actinomadura sp","author":"Kim","year":"1997","journal-title":"J. Microbiol. Biotechnol"},{"key":"10.1016\/j.ejphar.2014.04.024_bib24","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/0016-5085(84)90202-6","article-title":"Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models","volume":"87","author":"Krawisz","year":"1984","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2014.04.024_bib25","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/carcin\/bgm152","article-title":"Id-1 activation of PI3K\/Akt\/NF\u03baB signaling pathway and its significance in promoting survival of esophageal cancer cells","volume":"28","author":"Li","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ejphar.2014.04.024_bib26","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJM199406303302601","article-title":"Cyclosporine in severe ulcerative colitis refractory to steroid therapy","volume":"330","author":"Lichtiger","year":"1994","journal-title":"N. Eng. J. Med."},{"key":"10.1016\/j.ejphar.2014.04.024_bib27","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/gut.52.2.172","article-title":"Cyclosporin for refractory ulcerative colitis","volume":"52","author":"Loftus","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.ejphar.2014.04.024_bib28","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1136\/gut.2008.157297","article-title":"Use of sirolimus (rapamycin) to treat refractory Crohn\u05f3s disease","volume":"57","author":"Massey","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.ejphar.2014.04.024_bib29","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/gut.42.4.470","article-title":"Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation","volume":"42","author":"Nikolaus","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.ejphar.2014.04.024_bib30","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s00535-011-0502-y","article-title":"Regulatory T cells expanded by rapamycin in vitro suppress colitis in an experimental mouse model","volume":"47","author":"Ogino","year":"2012","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2014.04.024_bib31","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/43466","article-title":"NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase","volume":"401","author":"Ozes","year":"1999","journal-title":"Nature"},{"issue":"Suppl. 2","key":"10.1016\/j.ejphar.2014.04.024_bib32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2036.1996.22164024.x","article-title":"Regulatory cytokines in inflammatory bowel disease","volume":"10","author":"Pallone","year":"1996","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2014.04.024_bib33","first-page":"705","article-title":"Role of gut flora in inflammatory bowel disease-a state of art","author":"Paul","year":"2007","journal-title":"Communicating Current Research and Educational Topics and Trends in Applied Microbiology"},{"key":"10.1016\/j.ejphar.2014.04.024_bib34","first-page":"5185","article-title":"Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis","volume":"11","author":"Peran","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2014.04.024_bib35","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1053\/bega.2002.0354","article-title":"The current future understanding of inflammatory bowel disease","volume":"16","author":"Podolsky","year":"2002","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.ejphar.2014.04.024_bib36","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/ibd.20501","article-title":"Leukocyte adhesion molecules in animal models of inflammatory bowel disease","volume":"14","author":"Rivera\u2010Nieves","year":"2008","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.ejphar.2014.04.024_bib37","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1128\/AAC.50.5.1701-1709.2006","article-title":"7-O-malonyl macrolactin A, a new macrolactin antibiotic from Bacillus subtilis active against methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and a small-colony variant of Burkholderia cepacia","volume":"50","author":"Romero-Tabarez","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejphar.2014.04.024_bib38","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.4049\/jimmunol.141.5.1665","article-title":"Induction of intercellular adhesion molecule 1 on primary and continuous cell lines by pro-inflammatory cytokines. Regulation by pharmacologic agents and neutralizing antibodies","volume":"141","author":"Rothlein","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2014.04.024_bib39","series-title":"Immunopathophysiology of Inflammatory Bowel Disease, Immunological Aspects of Gastroenterology","first-page":"217","author":"Schreiber","year":"2001"},{"key":"10.1016\/j.ejphar.2014.04.024_bib40","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00384-001-0366-3","article-title":"Abrogated lymphocyte infiltration and lowered CD14 in dextran sulfate induced colitis in mice treated with p65 antisense oligonucleotides","volume":"17","author":"Spiik","year":"2002","journal-title":"Int. J. Colorectal Dis."},{"key":"10.1016\/j.ejphar.2014.04.024_bib41","doi-asserted-by":"crossref","first-page":"G1298","DOI":"10.1152\/ajpgi.2000.279.6.G1298","article-title":"NK-1 antagonist reduces colonic inflammation and oxidative stress in dextran sulfate-induced colitis in rats","volume":"279","author":"Stucchi","year":"2000","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.ejphar.2014.04.024_bib42","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1124\/jpet.108.141887","article-title":"Clotrimazole ameliorates intestinal inflammation and abnormal angiogenesis by inhibiting interleukin-8 expression through a nuclear factor-kappaB-dependent manner","volume":"327","author":"Thapa","year":"2008","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1016\/j.ejphar.2014.04.024_bib43","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s12272-009-1416-6","article-title":"Inhibitory effects of clotrimazole on TNF-alpha-induced adhesion molecule expression and angiogenesis","volume":"32","author":"Thapa","year":"2009","journal-title":"Arch. Pharmacal Res."},{"key":"10.1016\/j.ejphar.2014.04.024_bib44","doi-asserted-by":"crossref","first-page":"592","DOI":"10.4049\/jimmunol.146.2.592","article-title":"Tumor necrosis factor combines with IL-4 or IFN-gamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms","volume":"146","author":"Thornhill","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2014.04.024_bib45","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.bbrc.2003.07.019","article-title":"mTOR integrates amino acid- and energy-sensing pathways","volume":"313","author":"Tokunaga","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2014.04.024_bib46","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00054725-200207000-00009","article-title":"Antiadhesion molecule therapy in inflammatory bowel disease","volume":"8","author":"van Assche","year":"2002","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.ejphar.2014.04.024_bib47","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/gut.40.4.443","article-title":"Tumour necrosis factor and Crohn\u05f3s disease","volume":"40","author":"Van Deventer","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.ejphar.2014.04.024_bib48","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature06005","article-title":"Unravelling the pathogenesis of inflammatory bowel disease","volume":"448","author":"Xavier","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2014.04.024_bib49","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0002-9440(10)64057-6","article-title":"Monocyte\/macrophage activation by normal bacteria and bacterial products: implications for altered epithelial function in Crohn\u05f3s disease","volume":"158","author":"Zareie","year":"2001","journal-title":"Am. J. Pathol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299914003094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299914003094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T11:07:46Z","timestamp":1689160066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299914003094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":49,"alternative-id":["S0014299914003094"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.04.024","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective effect of 7-O-succinyl macrolactin A against intestinal inflammation is mediated through PI3-kinase\/Akt\/mTOR and NF-\u03baB signaling pathways","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.04.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}